|
HY-147051-50mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-139253-10mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-25mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-5mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-50mg
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0]
|
|
Cancer-Kinase/protease
|
|
|
HY-139253-1mL
|
MedChemexpress LLC
|
MRIA9 [CAS 2750707-05-0] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-100370-10mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-5mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-50mg
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100370-1mL
|
MedChemexpress LLC
|
MRK-016 [CAS 342652-67-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-14174-10mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-100mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-5mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-50mg
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14174-1mL
|
MedChemexpress LLC
|
MRK-560 [CAS 677772-84-8] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-114209-10mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-100mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-25mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-5mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-50mg
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5]
|
|
Cancer-programmed cell death
|
|
|
HY-114209-1mL
|
MedChemexpress LLC
|
MRK-740 [CAS 2387510-80-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-153584-10mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-25mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-5mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
|
HY-153584-50mg
|
MedChemexpress LLC
|
MRK-898 [CAS 461450-30-6]
|
|
|
|
